no code implementations • 5 Oct 2022 • Nathaniel Braman, Prateek Prasanna, Kaustav Bera, Mehdi Alilou, Mohammadhadi Khorrami, Patrick Leo, Maryam Etesami, Manasa Vulchi, Paulette Turk, Amit Gupta, Prantesh Jain, Pingfu Fu, Nathan Pennell, Vamsidhar Velcheti, Jame Abraham, Donna Plecha, Anant Madabhushi
QuanTAV risk scores were prognostic of recurrence free survival in treatment cohorts chemotherapy for breast cancer (p=0. 002, HR=1. 25, 95% CI 1. 08-1. 44, C-index=. 66) and chemoradiation for NSCLC (p=0. 039, HR=1. 28, 95% CI 1. 01-1. 62, C-index=0. 66).
no code implementations • 1 Jul 2021 • Nathaniel Braman, Jacob W. H. Gordon, Emery T. Goossens, Caleb Willis, Martin C. Stumpe, Jagadish Venkataraman
Here, we predict the overall survival (OS) of glioma patients from diverse multimodal data with a Deep Orthogonal Fusion (DOF) model.
no code implementations • 22 Jan 2020 • Nathaniel Braman, Mohammed El Adoui, Manasa Vulchi, Paulette Turk, Maryam Etesami, Pingfu Fu, Kaustav Bera, Stylianos Drisis, Vinay Varadan, Donna Plecha, Mohammed Benjelloun, Jame Abraham, Anant Madabhushi
In a retrospective study encompassing DCE-MRI data from a total of 157 HER2+ breast cancer patients from 5 institutions, we developed and validated a deep learning approach for predicting pathological complete response (pCR) to HER2-targeted NAC prior to treatment.
no code implementations • 3 Dec 2018 • Nathaniel Braman, David Beymer, Ehsan Dehghan
We explore a solution for learning disease signatures from weakly, yet easily obtainable, annotated volumetric medical imaging data by analyzing 3D volumes as a sequence of 2D images.